Anderson Financial Strategies’s Biogen BIIB Stock Holding History

Anderson Financial Strategies’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-40	Closed	-$5.47K	–	58
2025 Q1	$5.47K	Buy	+40	New	+$5.72K	﹤0.01%	181

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Anderson Financial Strategies's BIIB Position: Q2 2025 in Review

Anderson Financial Strategies sold out of Biogen (BIIB) in Q2 2025, closing a stake of 40 shares — an estimated $5.47K sold.

Anderson Financial Strategies first reported a position in BIIB in Q1 2025 and held it in 1 quarter. The position peaked at $5.47K in Q1 2025. 866 funds tracked by Wall St. Rank hold BIIB as of Q2 2025.

Anderson Financial Strategies reported no remaining Biogen position as of Q2 2025 after selling out during the quarter.
Anderson Financial Strategies sold 40 Biogen shares in Q2 2025, an estimated $5.47K.
Anderson Financial Strategies first reported a position in Biogen in Q1 2025 and held it in 1 quarter.
Anderson Financial Strategies's Biogen position peaked at $5.47K in Q1 2025.
866 funds tracked by Wall St. Rank held Biogen as of Q2 2025.

Based on Anderson Financial Strategies's 13F filing for Q2 2025, filed 11 Aug 2025.